AstraZeneca to make Oxford University's potential COVID-19 vaccine

(Reuters) - AstraZeneca will make and distribute globally the University of Oxford's potential COVID-19 vaccine, the British drugmaker said on Thursday. The Cambridge-based company did not give details on when it will start producing the vaccine for COVID-19, the disease caused by the new coronavirus, which has so far infected over 3 million people and killed more than 215,000.While there are more than 70 vaccines in development for the coronavirus, industry experts say they expect development..